UK group joins 9 other countries demanding end to mRNA vaccines
To: The Right Honourable Sir Keir Starmer, Prime Minister
Date; 25th November 2024
Notice of extreme concern about COVID-19 modified mRNA vaccine safety and quality to prime ministers and governing bodies of the Nordic and Baltic countries and the United Kingdom.
Excessive levels of residual DNA were identified in Australian samples,[i] confirming data from France,[ii] Germany,[iii] Canada,[iv] and the USA.[v]
The introduction of foreign DNA into cells via lipid nanoparticles (LNPs)[vi] may damage human DNA leading to genomic instability, cancer, and other extremely serious conditions.
As an international group of politicians and qualified professionals, we are gravely concerned about the effects of COVID-19 modified mRNA vaccines on our populations and call for their immediate suspension. We wish to focus your attention on three critical issues regarding the deployment of COVID-19 modified mRNA products that have profound implications for the health of our nations’ citizens.
- COVID-19 vaccines were never tested for their ability to block viral transmission.[vii] Hence, medical product regulators, as well as governments and governmental bodies, misled people in order to coerce them into accepting these products.
- COVID-19 vaccines resulted in an unprecedented level of reported side effects,[viii] including deaths.[ix] Reproducible analyses of public data [x],[xi],[xii],[xiii] shows that it was a lottery as to which batch a person received and the side effects that they may have experienced.
- Analyses by multiple, independent scientists evidence variable and excessive levels of residual plasmid DNA in vials of Pfizer and Moderna’s products – this foreign DNA is a by-product of the manufacturing processes and should never have made it into commercial vialsi-v.
The above points raise critical but unquantified risks for human health that have been systematically avoided by the regulatory authorities charged with their oversight. Therefore, on behalf of the public we call for:
- An immediate halt to the use of COVID-19 modified mRNA vaccines and a product recall;
- An independent and transparent investigation into their approval and use;
- Scientific evidence that documents that there is absolutely no risk of damage to human DNA.
For more detailed information please see the accompanying scientific summary.
Considering this information, we ask for clear answers to the following questions:
- What is required to set up an independent and transparent public and forensic inquiry into the regulatory processes leading to the approval of these products?
- Is there anything that prevents the minister from initiating and prioritizing research into potential links between mRNA vaccines and cancer, infertility, or other acute, chronic and genetic diseases.
With this scientifically supported threat to current human health and that of future generations, we have identified the risk. We respectfully ask that you act in the interest of your country’s citizens, upon which you were elected.
With the utmost concern and respect,
Dr Rosamond Jones, MBBS, MD, FRCPCH, on behalf of the UK members of the NORTH group
Signatories from the United Kingdom
Professor Angus Dalgleish, MD FRACP FRCP FRCPath FMedSci, Principal of the Institute of Cancer Vaccines and Immunotherapy, Emeritus Professor of Oncology, University of London
Professor Paul Goddard, MBBS MD FRCR FBIR, retired Professor of Radiology, University of the West of England
Professor Anthony J Brookes, Professor of Genomics and Health Data Science, University of Leicester
Professor John Fairclough, FRCS FFSEM, retired Honorary Consultant Surgeon
Professor David Livermore, BSc PhD, Emeritus Professor of Medical Microbiology, University of East Anglia
Professor Richard Ennos, MA PhD, Honorary Professorial Fellow, University of Edinburgh
Professor David Paton, Professor of Industrial Economics, Nottingham University
Professor Roger Watson, FRCP(Edin) FRCN FAAN, Honorary Professor of Nursing, University of Hull
The Lord Moonie, MBChB MRCPsych MFCM MSc, Life peer, retired member of the House of Lords, Parliamentary Under-Secretary of State 2001-2003, former Consultant in Public Health Medicine
Dr Alan Mordue, MBChB FFPH, Retired Consultant in Public Health Medicine & Epidemiology.
Dr Abby Astle, MBBChir BA(Cantab) DCH DGM MRCGP, GP Principal, GP Trainer, GP Examiner
Dr Alison Sabine, MBChB MRCP, Consultant Rheumatologist
Dr Ancha Bala-Joof, BSc MBChB MRCGP, General Practitioner
Andrew Bridgen, Former Member of Parliament, North West Leicestershire 2010-2024
Mr Anthony Hinton, MBChB FRCS, Consultant ENT surgeon, London
Dr Aseem Malhotra, MBChB MRCP, Consultant Cardiologist
Dr Alistair J Montgomery, MBChB MCGP DRCOG, Retired General Practitioner
Dr Angela Musso, MD, MRCGP, DRCOG, FRACGP, MFPC, General Practitioner
Dr Angharad Powell, MBChB BSc(Hons) DFSRH DCP(Ireland), DRCOG DipOccMed MRCGP, General Practitioner
Dr Ayiesha Malik, MBChB MRCGP(2014), Integrative Medical Doctor, Doctors For Patients UK and co-founder of The Hope Accord
Dr Caroline Lapworth, MB ChB, General Practitioner
Catherine Cassell, RGN, Practice Nurse
Dr Christina Peers, MBBS DRCOG DFSRH FFSRH, Menopause Specialist
Dr Christine Dewbury, MBBS, retired General Practitioner
Dr Christine Suppelt, MD FRCS MFHom, Ophthalmic Surgeon & Specialist for Integrated Medicine
Dr Chris Newton, PhD, Biochemist working in immuno-metabolism
Dr Clare Craig, BMBCh FRCPath, Diagnostic Pathologist, co-chair of HART group.
Dr David Critchley, BSc PhD in Pharmacology, 32 years’ experience Pharmaceutical R&D
Dr David Cartland, MBChB BMedSci, General practitioner
Mr David Halpin, MBBS FRCS, Orthopaedic and Trauma Surgeon, retired
Dr David Morris, MBChB MRCP (UK), General Practitioner
Dr Elizabeth Burton, MBChB, Retired General Practitioner
Dr Elizabeth Evans, MA(Cantab) MBBS DRCOG, Retired Doctor, CEO UK Medical Freedom Alliance
Dr Emma Brierly, MBBS MRCGP, General Practitioner
Eshani King, BSc(Hons) FCA CTA BFP, Evidence Based Research in Immunology and Health
Dr Felicity Lillingston, IMD DHS PhD ANP, Doctor, Urgent Care, Research Fellow
Dr Francesca Mbow, MD(Italy) MRCGP DFFP, General Practitioner
Dr Fernando M Gundin, MRCGP (2017), General Practitioner
Dr Geoffrey Maidment, MBBS DRCOG MD FRCP, Retired Consultant Physician
Dr Gerry Quinn, PhD, Postdoctoral Researcher in Microbiology and Immunology
Dr Greta Mushet, MBChB MRCPsych, Retired Consultant Psychiatrist in Psychotherapy
Hedley Rees, BEng (Tech Hons) MBA, Advisory Board Member, International Institute of Advanced Purchasing and Supply, Pharmaflow Ltd
Helen Auburn, Dip ION MBANT CNHC, Nutritional Therapist
Dr Henry Goodall, MBBS FFOM, retired Consultant Occupational Health Physician, President of the Society of Occupational Medicine, 2011-12
Dr Ian Bridges, MBBS, General Practitioner retired
Mr Ian McDermott, MBBS MS FRCS(Tr&Orth) FFSEM(UK) Consultant Orthopaedic Surgeon
Dr James Dyson, MRCS LRCP MA, retired Medical Practitioner
James Cook, NHS Registered Nurse, Bachelor of Nursing (Hons), Master of Public Health (MPH)
Mr James Royle, MBChB FRCS MMedEd, Colorectal surgeon
Dr Janet Menage, MA MBChB, retired General Practitioner
Jessica Righart, MSc, Senior Biomedical Scientist
Dr Jessica Robinson, BSc(Hons) MBBS MRCPsych MFHom, Integrative Medicine Doctor.
Dr Johanna Reilly, MBBS, General Practitioner
Mr John Bunni, MBChB (Hons), Dip Lap Surg, FRCS [ASGBI Medal], Consultant Colorectal and General Surgeon
Dr John Flack, BPharm PhD, Retired, Director of Safety Evaluation, Beecham Pharmaceuticals, Senior Vice-president for Drug Discovery SmithKline Beecham
Dr John Sampson, MBBS, DMRD, retired doctor
Dr Jonathan Eastwood, BSc MBChB MRCGP, General Practitioner
Dr Jon Rogers, MBChB(Bristol) MRCGP DRCOG, Retired NHS General Practitioner
Joshua Knowles, Honorary Professor, Alliance Manchester Business School, Honorary Senior Fellow, School of Computer Science, University of Birmingham
Dr Julia Piper, FRCGP BMBS BMedSci DFFP AFMCP DipOccMed DipMedAcc
Julie Annakin, Registered Nurse, Immunisation Specialist Nurse, retired
Kaira McCallum, BSc, Retired Pharmacist, Director of Strategy UKMFA
Katherine MacGilchrist, BSc(Hons), MSc (Epidemiology), former CEO/Systematic Review Director, Epidemica Ltd
Dr Keith Dewbury, MBBS FRCR, Retired Consultant Radiologist
Dr Keith Johnson, BA DPhil (Oxon), IP Consultant for Diagnostic Testing
Dr Livia Tossici-Bolt, PhD, Retired Clinical Scientist
Dr Lucie Wilk, MD MRCP, Rheumatologist
Dr Marco Chiesa, MD FRCPsych, Consultant Psychiatrist & Visiting Professor, University College London
Dr Peter Chan, BM MRCS MRCGP NLP, General Practitioner, Functional Medicine Practitioner
Marco Tullio Suadoni, RN BSc(Hons) Adult Nursing MSc, Specialist Palliative Care Lead
Dr Mark A Bell, MBChB MRCP(UK) FRCEM, Consultant in Emergency Medicine
Dr Matthew Dennison, MBBS MRCGP Dip IBLM, General Practitioner
Dr Matthew Hicks, MBChB, NHS Specialty Doctor
Dr Noel Thomas, MA MBChB DObsRCOG DTM&H MFHom, Retired Doctor
Dr Phuoc-Tan Diep, MBChB FRCPath, Consultant Histopathologist
Dr Rachel Nicoll, PhD, Medical researcher
Dr Richard House, PhD CPsychol AFBPsS CertCouns, Chartered Psychologist, former senior lecturer, retired psychotherapist
Dr Richard J O’Shea, MBBCh BA(Hons) MRCGP, General Practitioner
Dr Rosamond Jones, MBBS DRCOG MD FRCPCH, retired Consultant Paediatrician, convenor CCVAC (Children’s Covid Vaccines Advisory Council)
Sarah Waters, BA(Hons) MBACP, Family and Adult Psychotherapist
Dr Sheena Fraser, MBChB, MRCGP (2003), Dip BSLM, General Practitioner
Sophie Gidet, Registered Midwife
Sorrel Scott, Grad Dip Phys, Specialist Physiotherapist in Neurology, 30 years in NHS
Dr Stefanie Williams, MD, Dermatologist
Stephen Jackson, Solicitor
Dr Stephen Ting, MBChB MRCP PhD, Consultant Physician
Dr Tanya Klymenko, PhD FHEA FIBMS, Senior Lecturer in Biomedical Sciences
Dr Tess Lawrie, MBBCh PhD, Director, Evidence-based Medicine Consultancy Ltd, Bath
Dr Thomas Carnwath, MBBCh MA FRCPsych FRCGP, retired Consultant Psychiatrist
Rev Dr William J U Philip, MBChB MRCP BD, Senior Minister, The Tron Church, Glasgow. Formerly Physician specialising in Cardiology
Dr Zenobia Storah, MA(Oxon) DClinPsy CPsychol, Child and Adolescent Clinical Psychologist.
This letter has been sent to the leaders of 10 northern European countries today with all the international signatures signatures available on the website at https://northgroup.info/
[i] Speicher (2024). https://russellbroadbent.com.au/wp-content/uploads/David-Speicher-Report-2.pdf
[ii] Raoult (2024). Confirmation of the presence of vaccine DNA in the Pfizer anti-COVID-19 vaccine. HAL Open Science. https://hal.science/hal-04778576v1/document
[iii] König & Kirchner (2024). Methodological Considerations Regarding the Quantification of DNA Impurities in the COVID-19 mRNA Vaccine Comirnaty. Methods Protoc. https://www.mdpi.com/2409-9279/7/3/41
[iv] Speicher et al. (2023). DNA fragments detected in monovalent and bivalent Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, Canada: Exploratory dose response relationship with serious adverse events. https://doi.org/10.31219/osf.io/mjc97
[v] McKernan et al. (2023). Sequencing of bivalent Moderna and Pfizer mRNA vaccines reveals nanogram to microgram quantities of expression vector dsDNA per dose. https://doi.org/10.31219/osf.io/b9t7m
[vi] Kämmerer U, Schulz V, Steger K (2024). https://publichealthpolicyjournal.com/biontech-rna-based-covid-19-injections-contain-large-amounts-of-residual-dna-including-an-sv40-promoter-enhancer-sequence/
[vii] European Medicines Agency (2023). EMA/451828/2023. https://www.dropbox.com/scl/fi/0tmz0c3ui0te9jq7qwt37/2023-10-18-Letter-to-MEP-Marcel-de-Graaff-Request-for-the-dire.pdf?rlkey=8hgl56ykrxoq7i4y2t11as9ub&e=1&dl=0
[viii] Faksova et al. (2024). COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals. https://www.sciencedirect.com/science/article/pii/S0264410X24001270
[ix] Eudravigilance (2024). https://www.adrreports.eu/en/index.html
[x] Schmeling et al. (2023). Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine. https://onlinelibrary.wiley.com/doi/10.1111/eci.13998
[xi] Manniche et al. (2024). Reports of Batch-Dependent Suspected Adverse Events of the BNT162b2 mRNA COVID-19 Vaccine: Comparison of Results from Denmark and Sweden. Medicina. https://doi.org/10.3390/medicina60081343
[xii] Fürst et al. (2024). Batch-dependent safety of COVID-19 vaccines in the Czech Republic and comparison with data from Denmark. https://onlinelibrary.wiley.com/doi/10.1111/eci.14271 [xii]
[xiii] Jablonowski & Hooker (2024). Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine in the United States. https://publichealthpolicyjournal.com/batch-dependent-safety-of-the-bnt162b2-mrna-covid-19-vaccine-in-the-united-states/
